These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28412826)

  • 41. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years.
    Morofuji-Hirata M; Kajiyama W; Nakashima K; Noguchi A; Hayashi J; Kashiwagi S
    Am J Epidemiol; 1993 Jan; 137(1):43-8. PubMed ID: 8434571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of human T-cell lymphotropic virus and the socio-demographic and risk factors associated with the infection among post-natal clinics women in Zaria, Nigeria.
    Hananiya HS; Ella EE; Aminu M; Anyanwu NCJ
    J Immunoassay Immunochem; 2019; 40(5):485-494. PubMed ID: 31339431
    [No Abstract]   [Full Text] [Related]  

  • 44. HTLV-1 and -2 in a first-time blood donor population in Northeastern Brazil: Prevalence, molecular characterization, and evidence of intrafamilial transmission.
    Ribeiro IP; Kozlowski AG; Dias de Matos MA; da Costa E Silva ÁM; Dos Santos Carneiro MA; Vicente ACP; Martins RMB
    J Med Virol; 2018 Oct; 90(10):1651-1657. PubMed ID: 29797609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.
    Furuta RA; Ma G; Matsuoka M; Otani S; Matsukura H; Hirayama F
    Transfusion; 2015 Apr; 55(4):880-9. PubMed ID: 25363675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rate of positive autoimmune markers in Human T lymphotropic virus type 1 carriers: a case-control study from Iran.
    Ahmadi Ghezeldasht S; Hedayati-Moghaddam MR; Habibi M; Mollahosseini F; Rafatpanah H; Miri R; Hatef Fard M; Sahebari M
    Int J Rheum Dis; 2018 Jan; 21(1):108-113. PubMed ID: 28261958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ethnic cluster of HTLV-I infection in Israel among the Mashhadi Jewish population.
    Miller M; Achiron A; Shaklai M; Stark P; Maayan S; Hannig H; Hunsmann G; Bodemer W; Shohat B
    J Med Virol; 1998 Nov; 56(3):269-74. PubMed ID: 9783697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seroprevalence of human T-lymphotropic virus type I (HTLV-I) in Saudi Arabia.
    Arif M; Ramia S
    Ann Trop Med Parasitol; 1998 Apr; 92(3):305-9. PubMed ID: 9713546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Seroepidemiology of human T-cell lymphotropic virus type I/II in Benin (West Africa).
    Dumas M; Houinato D; Verdier M; Zohoun T; Josse R; Bonis J; Zohoun I; Massougbodji A; Denis F
    AIDS Res Hum Retroviruses; 1991 May; 7(5):447-51. PubMed ID: 1873079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients.
    Santos RF; Conceição GC; Martins MS; Kraychete A; Penalva MA; Carvalho EM; Lopes AA; Rocha PN
    BMC Nephrol; 2017 Feb; 18(1):64. PubMed ID: 28202003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
    Kwon SY; Lim AH; Park JY; Han SH; Cho NS
    J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
    Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HTLV-1 seroprevalance in sarcoidosis. A clinical and laboratory study in northeast of Iran.
    Saghafi M; Rezaieyazdi Z; Nabavi S; Mirfeizi Z; Sahebari M; Salari M
    Int J Rheum Dis; 2018 Jun; 21(6):1309-1313. PubMed ID: 28185411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of human T-lymphotropic virus in civilian applicants for the United States Armed Forces.
    Roberts CR; Fipps DR; Brundage JF; Wright SE; Goldenbaum M; Alexander SS; Burke DS
    Am J Public Health; 1992 Jan; 82(1):70-3. PubMed ID: 1536338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unusual finding of HTLV-I infection among Amazonian Amerindians.
    Barros Kanzaki LI; Casseb J
    Arch Med Res; 2007 Nov; 38(8):897-900. PubMed ID: 17923274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
    Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia.
    Khameneh ZR; Baradaran M; Sepehrvand N
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):838-41. PubMed ID: 18711311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2.
    Dezzutti CS; Guenthner PC; Daniel S; Utz U; Cabrera T; Marshall JH; Bianco C; Lal RB; Cowan EP
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):715-7. PubMed ID: 12853410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Results of 1-year screening of donors in The Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection.
    Zaaijer HL; Cuypers HT; Dudok de Wit C; Lelie PN
    Transfusion; 1994 Oct; 34(10):877-80. PubMed ID: 7940659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.